Evidence map›Paper›PMID 42205476›Full record

ArticleFrontiers in cellular and infection microbiology2026

Defining reference values for the gut microbiota in a Southern European population.

Chiara Pollicardo, Franca Gotta, Paolo Bottino, Daria Vay, Valentina Pizzo, Sara Scaglione, Giulia Pontarollo, Marialuisa Novi, Lara Boatti, Flavio Mignone and 3 more

Abstract read
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Chiara PollicardoDepartment of integrated Surgical and Diagnostic Science (DISC), University of Genova, Genova, Italy.
Franca GottaMicrobiology and Virology Laboratory, University Hospital "SS. Antonio e Biagio e C. Arrigo", Alessandria, Italy.
Paolo BottinoMicrobiology and Virology Laboratory, University Hospital "SS. Antonio e Biagio e C. Arrigo", Alessandria, Italy.
Daria VayMicrobiology and Virology Laboratory, University Hospital "SS. Antonio e Biagio e C. Arrigo", Alessandria, Italy.
Valentina PizzoMicrobiology and Virology Laboratory, University Hospital "SS. Antonio e Biagio e C. Arrigo", Alessandria, Italy.
Sara ScaglioneDepartment of Translational Medicine, Eastern Piedmont University, Novara, Italy.
Giulia PontarolloMicrobiology and Virology Laboratory, University Hospital "SS. Antonio e Biagio e C. Arrigo", Alessandria, Italy.
Marialuisa NoviGastroenterology Unit, University Hospital "SS. Antonio e Biagio e C. Arrigo", Alessandria, Italy.
Lara BoattiArrow Diagnostics Ltd, Genova, Italy.
Flavio MignoneSmartSEQ Ltd, Alessandria, Italy.
Giovanni MelioliAlliance Medical Diagnostic Ltd, Genova, Italy.
Fabio RapalloDepartment of Economics, University of Genova, Genova, Italy.
Andrea RocchettiMicrobiology and Virology Laboratory, University Hospital "SS. Antonio e Biagio e C. Arrigo", Alessandria, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: The clinical implementation of gut microbiota analysis requires the definition of reliable reference values derived from standardized and certified methodologies applied to a population representative of the intended clinical setting. Methods: In this study, 250 fecal samples were analyzed using a CE-certified 16S rRNA bacterial profiling assay for taxonomic characterization across multiple bacterial levels. Sequencing reads were quality-filtered and aligned against the RDP database (release 11, update 5); only sequences with ≥80% alignment coverage and ≥97% similarity were retained. Results: The resulting taxonomic distributions were first compared with data previously obtained from a similar population, revealing only minor differences. As an additional validation, comparative analyses were performed with data from a clinical study on fecal microbiota transplantation (FMT). Donor profiles were highly consistent with those obtained in the present study, whereas pre-transplant samples showed marked deviations from the reference ranges; post-transplant profiles progressively converged toward them. Discussion: Although the limited sample size precludes accurate assessment of rare taxa (<0.1% relative abundance), the use of a single Next-Generation Sequencing (NGS) platform and the focus on a Southern European population characterized by the Mediterranean diet allowed the establishment of the first set of gut microbiota reference values derived from a certified

Indexed as

BacteriaGastrointestinal MicrobiomeAdultDNA, BacterialEuropeEuropean PeopleFecal Microbiota TransplantationFecesFemaleHigh-Throughput Nucleotide SequencingHumansMaleReference ValuesRNA, Ribosomal, 16SSequence Analysis, DNADNA, BacterialRNA, Ribosomal, 16S16Sfecal microbiota transplantationgut microbiotahealthy populationreferences valuessequencingSouthern Europe

Identifiers

PMID42205476
PMCPMC13201392

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.